Skip to content
Screener

Astera Labs, Inc. ALAB Accrued expenses and other liabilities

Accrued expenses and other liabilities at other companies

Arteris, Inc. logo
Arteris, Inc.AIP
-$6.34M-221%
Marvell Technology, Inc. logo
Marvell Technology, Inc.MRVL

Other financials

Income statement

See full
Revenue$392.4M+104%
Gross profit$287.6M+97.6%
Operating income$89.2M+124%
Net income$153.1M+199%
EPS (diluted)$0.83+186%

Balance sheet

See full
Cash & equivalents$111.5M-31.8%
Total debt$44.4M+37.5%
Total equity$1.7B+51.9%
Total assets$1.9B+51.9%

Cash flow

See full
Operating cash flow$87.7M-35.2%
CapEx$20.5M+912%
Free cash flow$67.2M-49.6%

Valuation

See full
Market cap$57.51B+98.4%
Enterprise value$57.44B+99.1%
P/E155.7×
P/S47.9×0.0×

Profitability

See full
Gross margin75.1%-0.4pp
Operating margin22.8%+15.8pp
Net margin30.7%
FCF margin23%-11.7pp

Returns & leverage

See full
Return on equity25.8%
Debt / equity0.0×
Current ratio10.1×-1.0×

Where this comes from

Reported directly by Astera Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The source filing: Astera Labs, Inc.’s 10-Q, filed May 6, 2026.

Filed
May 5, 2026, 8:00 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001736297-26-000020
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Inventory346(6,787)
Prepaid expenses and other assets13,889(14,495)
Accounts payable(699)2,226
Accrued expenses and other liabilities(20,841)(12,365)
Net cash provided by operating activities74,59810,504
Cash flows from investing activities
Purchases of property and equipment(7,586)(4,539)
Purchases of marketable securities(156,628)(190,821)

ITEM 1. Financial Statements (Unaudited)

FAQ

What is Astera Labs, Inc.'s accrued expenses and other liabilities?
Astera Labs, Inc. (ALAB) reported accrued expenses and other liabilities of -$20.84M in Q1 2026.
How has Astera Labs, Inc.'s accrued expenses and other liabilities changed year-over-year?
Astera Labs, Inc.'s accrued expenses and other liabilities decreased by 68.5% year-over-year, from -$12.37M to -$20.84M.
What is the long-term trend for Astera Labs, Inc.'s accrued expenses and other liabilities?
Over 2 years (2022 to 2024), Astera Labs, Inc.'s accrued expenses and other liabilities has grown at a 39.6% compound annual growth rate (CAGR), from $15.95M to $31.09M.
What does accrued expenses and other liabilities mean?
Accrued expenses and other liabilities

Ask your AI about Astera Labs, Inc.'s accrued expenses and other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude